A detailed history of Cibc World Markets Corp transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Cibc World Markets Corp holds 25,074 shares of CPRX stock, worth $492,453. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,074
Previous 10,463 139.64%
Holding current value
$492,453
Previous $218,000 178.9%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$19.53 - $25.74 $285,352 - $376,087
14,611 Added 139.64%
25,074 $608,000
Q4 2024

Feb 10, 2025

BUY
$19.73 - $23.93 $206,434 - $250,379
10,463 New
10,463 $218,000

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.02B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Cibc World Markets Corp Portfolio

Follow Cibc World Markets Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.